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Microcomputed tomography (microCT) has become a
standard and essential tool for quantifying structure-
function relationships, disease progression, and
regeneration in preclinical models and has facilitated
numerous scientific and bioengineering advancements
over the past 30 years. In this article, we recount the
early events that led to the initial development of
microCT and review microCT approaches for quantitative
evaluation of bone, cartilage, and cardiovascular
structures, with applications in fundamental structure-
function analysis, disease, tissue engineering, and
numerical modeling. Finally, we address several
next-generation approaches under active investigation
to improve spatial resolution, acquisition time, tissue
contrast, radiation dose, and functional and molecular
information.Introduction
Microcomputed tomography (microCT or μCT) is a
non-destructive imaging tool for the production of high-
resolution three-dimensional (3D) images composed of
two-dimensional (2D) trans-axial projections, or ‘slices’,
of a target specimen. MicroCT equipment is composed
of several major components: x-ray tube, radiation filter
and collimator (which focuses the beam geometry to
either a fan- or cone-beam projection), specimen stand,
and phosphor-detector/charge-coupled device camera
(Figure 1). Reconstruction of a 3D image is performed
by rotating either the sample (for desktop systems) or
the emitter and detector (for live animal imaging) to
generate a series of 2D projections that will be trans-
formed to a 3D representation by using a digital process* Correspondence: jboercke@nd.edu
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unless otherwise stated.called back-projection [1,2]. This non-destructive im-
aging modality can produce 3D images and 2D maps
with voxels approaching 1 μm, giving it superior reso-
lution to other techniques such as ultrasound and mag-
netic resonance imaging (MRI) [2].
The principle of microCT is based on the attenu-
ation of x-rays passing through the object or sample
being imaged. As an x-ray passes through tissue, the
intensity of the incident x-ray beam is diminished ac-
cording to the equation, Ix = I0e
−μx, where I0 is the in-
tensity of the incident beam, x is the distance from
the source, Ix is the intensity of the beam at distance
x from the source, and μ is the linear attenuation co-
efficient [3]. The attenuation therefore depends on
both the sample material and source energy and can
be used to quantify the density of the tissues being
imaged when the reduced intensity beams are col-
lected by a detector array.Historical context
In 1979, Allan Cormack and Godfrey Hounsfield were
awarded the Nobel Prize in Physiology or Medicine for
the development of computer-assisted tomography and,
by the late 1970s, clinical computed tomography (CT)
was in widespread use; however, these systems were lim-
ited in resolution and yielded only 2D reconstructions
as they relied on line x-rays and linear array detectors.
In the early 1980s, Ford Motor Company physicist Lee
Feldkamp developed the first microCT system to evalu-
ate structural defects of ceramic automotive materials.
Expanding on the concepts of clinical CT systems, Feld-
kamp conceived of using a cone-beam x-ray source and
2D detector and rotating the sample itself through 360°.
He then developed the cone-beam algorithm to recon-
struct fully 3D images from those projections [4]. A ser-
endipitous meeting between Feldkamp and Michael
Kleerekoper of Henry Ford Hospital led to the first scan
of bone tissue, an iliac crest biopsy, and resulted in the
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Figure 1 Principal components of a microcomputed tomography scanner. A micro-focus x-ray tube, or synchrotron emitter for monochromatic
beam generation, produces radiation, which is collimated and passed through the object. The radiation is attenuated by the sample, and this
attenuation is measured by a charge-coupled device (CCD) camera with a phospholayer coating to convert x-rays to visible light. A three-
dimensional rendering of the sample is achieved by scanning at different angles of rotation and reconstructing through transformation of
two-dimensional projections.
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Mineral Research [5].
That same year, through connections at Henry Ford
Hospital, Feldkamp was introduced to Steven Gold-
stein, an orthopedic biomechanician at the University
of Michigan. Goldstein would name the technique
‘microcomputed tomography’, and this collaboration
led to the first publication of microCT analysis of
bone architecture, an evaluation of subchondral bone
in experimental osteoarthritis [6]. This was followed
shortly by the now well-known initial trabecular bone
microstructure article [7]. In 1984, Goldstein repli-
cated the Feldkamp microCT system in his laboratory,
establishing the first university microCT system, and
in the ensuing years it became clear that microCT
would revolutionize the fields of bone biology and
biomechanics. Several commercial microCT systems
are now available worldwide, and new innovations
continue to expand its speed, resolution, and applic-
ability to non-mineralized tissues.
This review discusses microCT approaches for quantita-
tive evaluation of bone, cartilage, and cardiovascular struc-
tures, with applications in fundamental structure-function
analysis, disease, tissue engineering, and numerical model-
ing, and addresses next-generation systems under active
investigation and development.
Bone structure, disease, and adaptation
MicroCT is established as an essential tool for evalu-
ating bone structure and quality and has been usedto study metabolic bone diseases such as osteoporosis
(Figure 2), to evaluate preclinical models of disease
[8], and to test the efficacy of anti-resorptive and ana-
bolic therapeutics, such as bisphosphonates [9]. One
emerging technique for microCT-based evaluation of
bone fragility induced by loading, aging, or osteopor-
otic disease is the use of contrast agents to detect
and quantify bone microdamage. For example, barium
sulfate (BaSO4) allows 3D assessment of exposed cal-
cium to quantify fatigue microdamage in bovine tra-
becular (Figure 3) [10,11].
MicroCT is now also a standard technique for evalu-
ation of genomic factors on bone phenotype through
the use of genomic and tissue-specific knockout mice,
as reviewed elsewhere [12,13]. For example, Wang and
colleagues [14] used microCT analysis of both bone
and vascular structures to show that deletion of von
Hippel-Lindau, which regulates expression of the an-
giogenic growth factor vascular endothelial growth fac-
tor through modulating hypoxia-inducible factor (HIF)
1α degradation, resulted in exceedingly dense, highly
vascularized long bones, but normal calvariae, whereas
the HIF1α knockouts had the opposite long-bone
phenotype. Interestingly, the double knockout exhib-
ited increased long-bone formation and vascularization,
enabling identification of a compensatory function of
the HIF2α subunit.
MicroCT imaging affords unique capabilities for non-
destructive reconstruction of microstructural features,
enabling approaches such as finite element (FE) analysis
Figure 2 Microcomputed tomography (microCT) reconstruction of cortical and trabecular bone. MicroCT enables high-resolution three-
dimensional reconstruction of microstructural characteristics from trabecular architecture to cortical porosity. (A) Trabecular bone from femoral
neck of 51-year-old male (left) and 84-year-old female (right). (B) Diaphyseal femoral cortical bone of 18-year-old male (left) and 73-year-old
female (right). Age, gender, disease, and other factors influence the microstructural properties of both cortical and trabecular bone, and these can
be evaluated quantitatively by microCT.
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loading conditions. This method allows virtual recapitu-
lation of experimental or physiologic boundary condi-
tions to estimate local stresses and strains within a tissue
of complex geometry [15]. Important considerations for
accurate FE analysis of biological tissues include mesh
formulation and resolution, constitutive models that re-
capitulate salient features of tissue behavior, appropriate
boundary conditions, and model size and convergence.
Mesh generation may be accomplished either through
custom, specimen-specific meshes featuring smooth
boundaries and unstructured grids or through directconversion of digital voxels to hexahedral brick ele-
ments. Direct, digital FE models are the easiest to create
but may be limited by large model sizes and inaccuracies
or instabilities at model or material boundaries, requir-
ing at least four digital FEs through a beam cross-
section for accuracy [16,17].
Appropriate constitutive model selection is critical
for analysis of biological materials, including bone. Al-
though numerous constitutive formulations have been
employed, a universally applicable model has not
been identified, and formulation should be carefully
considered for each application. For example, some
Figure 3 Contrast-enhanced imaging of mechanical load-
induced bone microdamage in rat femora. Samples were loaded
in three-point bending to 5% or 10% reduction in secant modulus
and stained by barium sulfate (BaSO4) precipitation. Load-induced
microcracks provide nucleation sites for barium and sulfate ions to
accumulate. BaSO4 signal featured a linear attenuation coefficient
approximately three times that of rat cortical bone, enabling
co-registration of microdamage by microcomputed tomography.
Reproduced with permission from Elsevier [10].
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local Young’s modulus or ultimate stress with
microCT-measured local density, either linearly or,
more accurately, using a power-law relationship
[18-20]. Others have coupled non-linear local constitu-
tive models with microCT-based FE models to predict
local plasticity and macroscopic failure of trabecular
bone and to relate bone microarchitectural features
with apparent-level mechanical behavior [21,22]. In-
trinsic mechanical properties can also be validated dir-
ectly through local measurement by nanoindentation
[22] or at the effective level by comparison and scaling
with mechanical tests [23]. Finally, accurate physio-
logical boundary conditions are frequently difficult to
quantify but may be estimated by inverse dynamics,
direct muscle force measurement by electromyography,
scaling muscle reaction forces with muscle length orphysiological cross-sectional area, or through objective
optimization approaches [24].
Current applications of microCT-based FE modeling
include evaluation of bone quality, microdamage and
failure [25-27], effects of mechanical stimuli on bone re-
generation [23,28,29], mechanical regulation of tissue
differentiation and remodeling [30-32], and fluid–struc-
ture interactions of bone marrow within trabecular
bone [33,34]. The non-destructive nature of microCT
further makes it ideal for longitudinal evaluation of
disuse- and mechanical load-induced bone remodeling
and adaptation [35,36]. For example, Müller and col-
leagues [37-39] have recently published a series of arti-
cles using time-lapse in vivo microCT and FE analysis in
a mouse tail vertebra model to longitudinally evaluate
the effect of compressive loading or unloading on local
bone formation and resorption (Figure 4). Locations of
bone formation and resorption correlated with sites of
high- and low-strain energy density, respectively, and
bone modeling/remodeling did not exhibit a ‘lazy zone’
as predicted by the long-accepted Frost mechanostat
theory [40].
Space limitations prevent comprehensive discussion of
the many applications of microCT to bone biomechanics
and mechanobiology. We refer interested readers to sev-
eral excellent focused reviews [2,41,42].
Tissue engineering
MicroCT emerged as a commercially available tool in
the middle of the ‘go-go’ years of tissue engineering
(that is, the 1980s and 1990s) [43], positioning it
perfectly for widespread use as the problems targeted
by tissue engineers necessitate non-destructive, 3D,
quantitative imaging techniques. Tissue engineering
approaches have remarkable potential to regenerate
damaged and diseased tissues, but increasing evi-
dence highlights the need for control of biomaterial
properties to meet the biomechanical and biological
requirements of complex tissues and organs. Scaf-
folds must balance mechanical properties with deg-
radation kinetics and byproducts, sufficient porosity
for cellular infiltration and seeding, and drug delivery
characteristics, among other criteria [44]. Thus, non-
destructive quantification of microstructural charac-
teristics such as porosity, surface-to-volume ratio,
interconnectivity, and anisotropy is necessary for
scaffold optimization [1,45], and microCT has the
potential to provide comprehensive data on these pa-
rameters [46].
Scaffold porosity and pore interconnectivity are key
factors in biomaterial design to enable cell migration,
proliferation, and extracellular matrix production and
facilitate tissue in-growth and blood vessel invasion
but come with trade-offs in other scaffold parameters,
Figure 4 Correlation of local tissue strains with regions of bone formation and resorption by longitudinal in vivo microcomputed
tomography (microCT) and finite element (FE) analysis. The sixth caudal vertebra of mice were loaded by pinned compression of the fifth
and seventh vertebrae, resulting in a cyclic load of 9 N. Serial, co-registered microCT scans were analyzed to determine locations of bone formation
and resorption (A) and correlated with locations of high/low strain energy density (SED) (B), calculated by FE analysis. Bone formation and
resorption were significantly more likely in regions of high and low SED, respectively. Reproduced with permission from PLOS [39].
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Lin and colleagues [49] used microCT to demonstrate
the effect of longitudinal macroporosity and porogen
concentration on volume fraction, strut density, and
anisotropy in oriented porous scaffolds. MicroCT has
become a critical tool for quantitative and non-
destructive assessment of internal scaffold microstruc-
ture to guide scaffold design and manufacture [50-52]
and enables non-destructive evaluation of both micro-
structural and mechanical behavior of multi-phase
and fiber-reinforced scaffolds [51,53,54] as well as
longitudinal scaffold degradation [55].
MicroCT is also used to evaluate the ability of cell-
based tissue engineering bone constructs to form bio-
logic mineralized matrix in vitro [56,57]. These stud-
ies and others have demonstrated that osteogenic
differentiation of stem cells in vitro is dependent on
substrate material and microstructural characteristics
[58], cell source (for example, amniotic fluid- versus
bone marrow-derived mesenchymal cells) [56], and di-
mensional (that is, 2D versus 3D) [59] and biomech-
anical culture conditions [60]. Unlike other in vitro
osteogenesis assays, microCT enables longitudinal
quantification of the time course of mineralization in
3D without interfering with cell growth or mineral
production [57], an important feature for comparison
of various cell sources with different mineralization
kinetics [56].In addition to scaffold microstructure, microCT en-
ables assessment of tissue engineered bone formation
in animal models [61-65] (for example, high-density
stem cell-mediated bone regeneration of calvarial de-
fects) (Figure 5A). To evaluate the importance of
porosity and space for tissue regeneration, scaffolds
were created as described by Lin and colleagues [49],
modified by removal of a 1.5-mm diameter axially
oriented cylindrical core (Figure 5B), loaded with
3 μg rhBMP-2, and implanted in rat femoral bone
defects. Bone formation was localized predominantly
to the core space and outer surfaces of the scaffold,
indicating a failure of new bone formation to grow
into the scaffold itself (Figure 5C), and a hydrogel
delivery approach featuring a similar dose of rhBMP-
2 (2.5 μg) but without a structural scaffold resulted
in greater bone formation, throughout the defect
(Figure 5D) [66]. These data suggest that, in spite of
high and oriented porosity, structural scaffolds can
impede cellular infiltration and tissue regeneration,
warranting further research on the role of scaffold
porosity and orientation.
Excitingly, multiple companies now provide microCT
scanners with a stationary sample container and a
rotating gantry housing the x-ray emitter and de-
tector, allowing in vivo imaging of small animals (that
is, mice and rats) under anesthesia at resolutions
approaching those of standard desktop systems. These
BA C D
E
Figure 5 Microcomputed tomography (microCT) analysis of tissue engineering scaffolds and bone regeneration in vivo. (A) MicroCT
reconstruction of mesenchymal stem cell-mediated bone regeneration in a bilateral cranial defect model treated with a high-density human
mesenchymal stem cell (hMSC) construct incorporating growth factor-loaded microparticles (left) or empty control (right), and sagittal-cut views
of three-dimensional thickness mapping overlay of defect regions (Phuong Dang and Eben Aslberg, in preparation). (B) Poly(L/DL)-lactide
tri-calcium phosphate (PLDL-TCP) scaffold created according to the protocol of [38] featuring oriented microporosity and central core showing
isometric view and transverse cross-section. (C) In vivo bone formation in a rat femoral bone defect model implanted with cored scaffolds from
(A) loaded with rhBMP-2 in alginate hydrogel (McDermott and collegues, in preparation) or (D) hydrogel-mediated delivery of rhBMP-2 within a
polycaprolactone nanofiber mesh without a structural scaffold in the defect. Reproduced with permission from [49]. (E) In vivo microCT-based
longitudinal quantification of bone formation over time (dotted to solid lines) for various doses of BMP-2 in the hybrid nanofiber mesh/alginate
delivery system. Reproduced with permission from [49].
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integration and mineralization. For example, Boerckel
and colleagues [66] recently evaluated the time course
of bone regeneration in a rat segmental bone defect
model over 12 weeks to quantify the dynamics of bone
formation, mineralization, and maturation (Figure 5E).
Important considerations for in vivo microCT imaging
include consistent positioning of animals to minimize
system variability, volume of interest selection and
thresholding to avoid fixation hardware artifacts, and
dose of ionizing radiation. As these studies demonstrate,
advances in both desktop and in vivo microCT imaging
systems will continue to further the field of tissue engin-
eering in years to come.Vascular imaging
Evaluation of soft tissues by x-ray imaging requires
application of radiodense contrast agents. Contrast-
enhanced microCT angiography enables visualization
of cardiovascular structures, and emerging techniques
are enabling this analysis both ex vivo and in vivo.Ex vivo microcomputed tomography angiography
The use of microCT to study 3D vascular morphology
began with studies of reno-vascular architecture, in
which 3D casting of kidney vessels had been a common
visualization approach, dating back to the famed British
anatomist Sir William Bowman in the mid-19th century
[67]. It was therefore a natural progression from poly-
meric vascular casting combined with interstitial tissue
clearing agents (for example, methyl salicylate) [68] to
radiodense contrast-agent casting and CT. High-
resolution analysis of model animal vascular structures
by microCT was first conducted on renal microvascula-
ture in 1998 [69]. Today, ex vivo microCT angiography
is a powerful tool for 3D high-resolution evaluation of
post-natal vascular growth in models of tissue ischemia
(Figure 6) [70,71], tissue engineering (Figure 7) [28,72],
and tumor angiogenesis [73,74]. Owing to the small size
of arteriole and venule microvasculature and the diffi-
culty of efficient perfusion of potentially leaky vessels in
certain animal models, several variables must be consid-
ered depending on application, including contrast-agent




Figure 6 Microcomputed tomography angiography analysis of
hindlimb ischemia recovery. (A) Three-dimensional reconstructions
of distal hindlimb vasculature in wild-type (WT) (left) and MKP-1
knockout (KO) (right) mice at day 7 post-surgery. Reproduced with
permission from the American Heart Association [71]. (B) Quantification
of vascular volume ratio (ischemic/contralateral control), illustrating the
biphasic nature of angiogenic and arteriogenic vascular recovery. Initial
conditions (T0) taken from comparable WT C57Bl6 mice in [75], with
continuity indicated by gray lines. Horizontal line illustrates ischemic/
control ratio of 1.
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output parameters. Common vascular contrast agents
include microfil MV-122 and BaSO4/gelatin. Many of
these variables have been systematically addressed in a
hindlimb ischemia model [70].
Ex vivo microCT angiography has enabled novel ob-
servations of fundamental biological processes. For
example, serial perfusion and microCT scanning [75]
has demonstrated that the process of recovery from
hindlimb ischemia is analogous to the response profile
of an under-damped feedback control system, with a
biphasic recovery featuring an early vessel growth
phase resulting in vascular parameters exceeding
those of native vessel architecture and a later remod-
eling phase of vascular rarefaction and remodeling
back to normal parameters [71,75] (Figure 6A). A fur-
ther advantage of microCT is the ability to separate
3D regions of interest, enabling independent analysis
of the upper hindlimb, where arteriogenesis dominates
vascular recovery, and the distal hindlimb, where
angiogenesis dominates [71]. This approach is limitedby resolution, with voxel sizes typically around 20 μm.
As capillary beds have vessel diameters of 5 to 10 μm,
many vessels will be missed or registered as only
partial volumes; therefore, care must be taken during
interpretation regarding the detailed processes of
angiogenesis and arteriogenesis, and these larger-scale
measurements should be confirmed by immunohisto-
chemical analysis on the microvascular scale.
In the context of bone/vascular interactions, the
overlap in attenuation coefficients for bone and vascu-
lar contrast agents enables simultaneous segmentation
of bone and vascular structures (Figure 7A,B) but
requires decalcification and volume subtraction for
separate quantification (Figure 7D) and precludes
bone microstructural analyses (for example, connect-
ivity and density) other than volume [28]. Develop-
ment of novel contrast agents with non-overlapping
attenuation histograms or application of next-generation
microCT approaches (for example, spectral CT) would en-
able simultaneous segmentation of bone and vascularity
without decalcification.
In vivo microcomputed tomography angiography
Recent advances in intravenous microCT contrast
agents and cardiac and respiratory gating strategies
have enabled in vivo microCT imaging of cardiac and
vascular structures, albeit with reduced contrast, reso-
lution, and quantitative functionality compared to
ex vivo microCT angiography [76,77]. Briefly, in vivo
microCT angiography can be performed by using iodin-
ated monomer-based bolus (for example, iomeprol) or
lipid immulsion-based blood-pool (for example, Fenes-
tra VC, MediLumine Inc., Montreal, QC, Canada) con-
trast agents [76]. Owing to the short cardiac cycle and
rapid respiration rate of small rodents, gating strategies
(either prospective or retrospective) are required to
minimize motion artifacts. In prospective gating, acqui-
sition of images is initiated in response to a physio-
logical signal (for example, electrocardiography); in
retrospective gating, physiological signals are recorded
at the same time as image data to be sorted later [78].
Prospective gating can have long acquisition time but
wide-angular distribution, whereas retrospective gating
is characterized by fast scanning and irregular angular
distribution [76]. Developing new approaches to
achieve high-quality, quantitative in vivo microCT im-
aging remains an active area of research, and the most
successful to date have relied on custom microCT or
volumetric CT systems capable of rapid scan times and
high resolution [76,77].
Contrast-enhanced cartilage imaging
Recently, a radiopaque contrast agent has been devel-
oped to enable microCT imaging of non-mineralized
A B 
C D 
Figure 7 Microcomputed tomography (microCT) angiography of vascular response to bone injury and regeneration. (A) MicroCT image
of age-matched unoperated rat femur with surrounding vasculature: the large vessels on the right-hand side are the femoral artery and vein. (B)
Vascular structures and bone ends 3 weeks after creation of an 8-mm bone defect. There is a robust neovascular response to bone injury,
characterized by increased branching, new vessel formation, and decreased degree of vascular anisotropy. (C) MicroCT image of a nanofiber mesh
wrapped around a bone defect. Bone formation has occurred on the surface of the mesh, highlighting the mesh perforations. (D) MicroCT
angiography was used to visualize radially directed vascular ingrowth from the surrounding soft tissue envelope through the nanofiber mesh
perforations, illustrating the contribution of soft tissues to regenerate bone vascularization and the importance of biomaterial porosity. Owing to
the overlapping attenuation of bone and the lead chromate contrast agent, separate segmentation within the same sample is not possible
without extensive post-processing and image registration. Images reproduced with permission from the National Academy of Sciences [28]
(frames A and B) and from Elsevier [66] (frames C and D).
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normal cartilage extracellular matrix. Healthy articu-
lar cartilage contains a large amount of negatively
charged sulfated glycosaminoglycans (sGAG) such as
aggrecan, whereas the interstitial fluid carries posi-
tively charged solutes, resulting in net electroneutral-
ity [79]. However, the early stages of osteoarthritis are
characterized by a cleavage of these proteoglycans,
resulting in reduced sGAG content in the diseased
tissue. Palmer and colleagues [79] developed a tech-
nique called equilibrium partitioning of ionic contrast
agent via microCT (EPIC-microCT), in which the tis-
sue is equilibrated with the radiopaque, negatively
charged contrast agent, hexabrix (ioxaglate), which is
distributed inversely to the fixed negative charges onthe proteoglycan matrix, enabling simultaneous, non-
destructive microCT evaluation of both cartilage
morphology and composition (Figure 8) [80]. This
technique has been applied to evaluate numerous
normal and osteoarthritic disease models, including
rabbit [79], rat [81,82], mouse [83], dog [84], and goat
[85] as well as human cadaveric cartilage [86]. EPIC-
microCT has also been used to non-invasively image
cartilage degeneration longitudinally in vivo [87,88],
although challenges associated with contrast agent
leakage and equilibration time remain. In summary,
this technique promises to become a standard in ani-
mal model studies of osteoarthritis as it is non-
destructive and provides quantitative morphological
and compositional outcomes.
Figure 8 Equilibrium partitioning by ionic contrast-agent microcomputed tomography (EPIC-microCT). Experimental osteoarthritis was
induced by intra-synovial injection of monosodium iodoacetate (MIA) and evaluated at week 3 by EPIC-microCT. Excised rat femurs were
equilibrated with an ionic contrast agent (hexabrix) and scanned to assess cartilage and subchondral bone. The arthritic group exhibited substantial
sulfated glycosaminoglycan depletion, cartilage degradation, and subchondral bone resorption, illustrating the capacity of contrast-enhanced
microCT to quantitatively assess cartilage and bone in preclinical models of osteoarthritis. Arrows indicate location of complete cartilage
degradation in MIA group and corresponding location in the control. L, lateral; M, medial. Figure reproduced with permission from John
Wiley & Sons, Inc. [80].
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Advanced, composite, and next-generation microCT
imaging modalities are an active area of research.
One rapidly emerging technique that takes advantage
of x-ray intensity spectra instead of integrating at-
tenuation over the entire spectrum is spectral
microCT [89]. The theoretic framework for spectral
CT was established by Alvarez and Macovski in 1976,
when they demonstrated that dual-energy x-ray im-
aging enables deconvolution of the effects of Comp-
ton and photoelectric scattering, the two interactions
that contribute to the linear attenuation coefficient
[90]. Thus, precise local density mapping can be ac-
curately quantified [90,91]. This approach further
yields 3D information on atomic composition and
electron density [92], enables discrimination between
materials that would have the same attenuation in
standard microCT [89,93], and dramatically expands
the supply of contrast agents [93].
A second, rapidly evolving experimental microCT
imaging technique is phase-contrast microCT. This
powerful imaging modality bases image detection on
the phase shift of refracted x-rays rather than inten-
sity attenuation and promises increased tissue con-
trast and greater resolution for even soft tissues
without the need for contrast agents [94,95]. For
most biological materials, the phase shift of theincident x-ray is proportional to the sample mass
density, enabling high-contrast imaging of both soft
and hard tissues by microCT [95]. Recently, Tapfer
and colleagues, in collaboration with Bruker®
MicroCT (Bruker Corporation, Billerica, MA, USA),
described a rotating gantry phase-contrast microCT
system based on a polychromatic x-ray source [96]
that they have applied to ex vivo scans of a murine
pancreatic tumor model with soft tissue contrast
similar to MRI [97]. It is likely that in vivo phase-
contrast microCT imaging for small-animal models
will be established in the coming years, which will
represent a great advance in microCT imaging cap-
abilities.
Conclusions
MicroCT has contributed to dramatic advances in biol-
ogy and bioengineering over the past 30 years, enabling
fundamental studies in bone structure and function,
quantitative evaluation of disease progression and treat-
ment, development of new tissue engineering strategies,
and contrast-enhanced soft tissue imaging. Both desktop
and in vivo microCT systems are increasing in availabil-
ity and application, and continued advancements and in-
novations promise to continue this trajectory into the
future.
Note: This article is part of a thematic series on Functional
imaging in regenerative medicine. Other articles in the series can
be found online at http://stemcellres.com/series/FIRM.
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